-
Jun 15, 2023, 09:30 AM
by
MIB Agents, a leading pediatric osteosarcoma nonprofit dedicated to Making It Better for its community of patients, caregivers, doctors, and researchers, announced today that since its inception in 2016, it has awarded over $1.5 million to scientists across the country through its OutSmarting Osteosarcoma grant program. The OutSmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients and families who raise funds in honor of an OsteoWarrior, a patient currently battling osteosarcoma or an OsteoAngel, a loved one who has passed.
Full story
-
Jun 14, 2023, 10:14 AM
by
Torx ® Software Limited, a collaboration between Cresset and Elixir Software, has launched a new ground-breaking platform for small molecule discovery chemistry.
Full story
-
Jun 14, 2023, 10:14 AM
by
The global cancer gene therapy industry size accounted for USD 2.04 billion in 2022 and is estimated to achieve a market size of USD 12.75 billion by 2032 growing at a CAGR of 20.1% from 2023 to 2032.
Full story
-
Jun 14, 2023, 01:00 AM
by
User Not Found
Bio-IT World | Stanley T. Crooke, M.D., Ph.D., founder and longtime leader of the company that pioneered RNA-targeted therapeutics, is now chairman and CEO of the n-Lorem Foundation descaling the technology to treat patients helpless before a healthcare system that wasn’t built for “n-of-1” problems. He will be addressing a room of physicians and scientists tomorrow on the campus of Vanderbilt University.
Full story
-
Jun 13, 2023, 12:58 PM
by
Full story
-
Jun 13, 2023, 12:58 PM
by
Report reveals initial deployment of legacy systems has paved the way for imminent shift to modern software needed to accelerate AI-powered drug R&D
Full story
-
Jun 13, 2023, 12:58 PM
by
Kalderos’ 2023 annual report highlights costs of systemic challenges in drug discount programs and their impact on drug manufacturers, covered entities, payers and patients
Full story
-
Jun 13, 2023, 12:58 PM
by
Full story
-
Jun 13, 2023, 12:58 PM
by
Full story
-
Jun 13, 2023, 01:00 AM
by
User Not Found
Bio-IT World | BOSTON—The largest biotechnology conference in the world, the BIO International Conference, convened in Boston this week drawing over 20,000 attendees from more than 60 countries. In our post-pandemic world, the common thread throughout the conference was the need for global collaboration on our scientific challenges.
Full story
-
Jun 12, 2023, 10:57 AM
by
User Not Found
Bio-IT World | Illumina announced yesterday that Francis deSouza, Illumina's Chief Executive Officer and a Director, has resigned, effective Sunday, June 11.
Full story
-
Jun 8, 2023, 10:50 AM
by
Government initiatives towards preventive healthcare, growing funding & investments in R&D activities, adoption of direct-to-consumer approach, increasing applications in personalized medicine and growing burden of chronic diseases are some of the major factors driving the growth of cellular health screening market.
Full story
-
Jun 8, 2023, 10:50 AM
by
Full story
-
Jun 8, 2023, 10:50 AM
by
Full story
-
Jun 8, 2023, 10:50 AM
by
AARDEX Partners with Mevia to Test Evolution of Real-Time Adherence Technology
Integration of AARDEX MEMS AS and MEMS Mobile technology with Mevia's Medose dispenser offers opportunity to pilot next stage in reusable and real-time adherence solutions.
Full story
-
Jun 8, 2023, 10:50 AM
by
Landenberg site strengthens supply to support lifesaving therapeutics for global customers
Full story
-
Jun 8, 2023, 10:50 AM
by
Full story
-
Jun 8, 2023, 10:50 AM
by
Full story
-
Jun 8, 2023, 10:48 AM
by
Qlucore, listed on Nasdaq First North, can now present the first results from an EU-funded project for improved diagnosis of lung cancer. The new classification model not only separates different subgroups of primary lung cancer but also indicates whether the tumor sample is a metastasis of breast, colorectal, or kidney cell cancer.
Full story
-
Jun 8, 2023, 10:48 AM
by
Mural Health and ClinOne Partner to Maximize Patient Experience While Minimizing Site Burden
Strategic partnership integrates next-generation patient support and payment solutions for participants and sites alike
Full story